Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization
- 26 July 2005
- journal article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 83 (5), 621
- https://doi.org/10.1111/j.1600-0420.2005.00506.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young femalesAmerican Journal of Ophthalmology, 2004
- Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degenerationBritish Journal of Ophthalmology, 2004
- Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapyBritish Journal of Ophthalmology, 2004
- Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived FactorInvestigative Opthalmology & Visual Science, 2003
- Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology, 2003
- Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyesBritish Journal of Ophthalmology, 2003
- A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2003
- Intravitreal triamcinolone acetonide for exudative age related macular degenerationBritish Journal of Ophthalmology, 2003